Skip to content
lifestyle.onebyfourstudio.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Longeveron
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition
August 11, 2026
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
August 3, 2026
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
July 23, 2026
Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
June 9, 2026
Longeveron to Present at BIO International Convention 2026
June 4, 2026
Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
May 24, 2026
Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
May 24, 2026
Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2b Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (HLHS)
May 23, 2026
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
May 23, 2026
Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026
May 22, 2026
1
2
Next Page
→